SARS-CoV-2 nsp15 endoribonuclease antagonizes dsRNA-induced antiviral signaling
Proceedings of the National Academy of Sciences · 09.04.2024 · 121 (15)
DOI: 10.1073/pnas.2320194121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 03.04.2024. Verfasst von Clayton J Otter und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, University of Pennsylvania, Philadelphia, PA 19104. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, NIGMS NIH HHS, BLRD VA.
Abstract (Originalsprache)
Severe acute respiratory syndrome coronavirus (SARS-CoV)-2 has caused millions of deaths since its emergence in 2019. Innate immune antagonism by lethal CoVs such as SARS-CoV-2 is crucial for optimal replication and pathogenesis. The conserved nonstructural protein 15 (nsp15) endoribonuclease (EndoU) limits activation of double-stranded (ds)RNA-induced pathways, including interferon (IFN) signaling, protein kinase R (PKR), and oligoadenylate synthetase/ribonuclease L (OAS/RNase L) during diverse CoV infections including murine coronavirus and Middle East respiratory syndrome (MERS)-CoV. To determine how nsp15 functions during SARS-CoV-2 infection, we constructed a recombinant SARS-CoV-2 (nsp15 mut ) expressing catalytically inactivated nsp15, which we show promoted increased dsRNA accumulation. Infection with SARS-CoV-2 nsp15 mut led to increased activation of the IFN signaling and PKR pathways in lung-derived epithelial cell lines and primary nasal epithelial air–liquid interface (ALI) cultures as well as significant attenuation of replication in ALI cultures compared to wild-type virus. This replication defect was rescued when IFN signaling was inhibited with the Janus activated kinase (JAK) inhibitor ruxolitinib. Finally, to assess nsp15 function in the context of minimal (MERS-CoV) or moderate (SARS-CoV-2) innate immune induction, we compared infections with SARS-CoV-2 nsp15 mut and previously described MERS-CoV nsp15 mutants. Inactivation of nsp15 had a more dramatic impact on MERS-CoV replication than SARS-CoV-2 in both Calu3 cells and nasal ALI cultures suggesting that SARS-CoV-2 can better tolerate innate immune responses. Taken together, SARS-CoV-2 nsp15 is a potent inhibitor of dsRNA-induced innate immune response and its antagonism of IFN signaling is necessary for optimal viral replication in primary nasal ALI cultures.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, University of Pennsylvania, Philadelphia, PA 19104.
- Penn Center for Research on Coronaviruses and Other Emerging Pathogens, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104.
- Disease Intervention and Prevention, Texas Biomedical Research Institute, San Antonio, TX 78227.
- Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195.
- Department of Molecular Medicine, The Herbert Wertheim University of Florida Scripps Institute for Biomedical Innovation & Technology, Jupiter, FL 33458.
- Department of Immunology and Microbiology, The Herbert Wertheim University of Florida Scripps Institute for Biomedical Innovation & Technology, Jupiter, FL 33458.
ORCID-Profile: Clayton J Otter, Nicholas A Parenti, Chengjin Ye, Anthony R Fehr, Robert H Silverman, James M Burke, Luis Martinez-Sobrido, Susan R Weiss
Förderung
- NIAID NIH HHS
- NIGMS NIH HHS
- BLRD VA
- HHS | NIH | National Institute of Allergy and Infectious Diseases
- HHS | NIH | NIAID | Division of Microbiology and Infectious Diseases
- HHS | NIH | National Institute of General Medical Sciences
- U.S. Department of Veterans Affairs
Zitieren
APA
Otter, C. J., Bracci, N., Parenti, N. A., Ye, C., Asthana, A., Blomqvist, E. K., Tan, L. H., Pfannenstiel, J. J., Jackson, N., Fehr, A. R., Silverman, R. H., Burke, J. M., Cohen, N. A., Martinez-Sobrido, L., & Weiss, S. R. (2024). SARS-CoV-2 nsp15 endoribonuclease antagonizes dsRNA-induced antiviral signaling. Proceedings of the National Academy of Sciences, 121(15). https://doi.org/10.1073/pnas.2320194121
Vancouver
Otter CJ, Bracci N, Parenti NA, Ye C, Asthana A, Blomqvist EK, et al. SARS-CoV-2 nsp15 endoribonuclease antagonizes dsRNA-induced antiviral signaling. Proceedings of the National Academy of Sciences. 2024;121(15). doi:10.1073/pnas.2320194121
BibTeX
@article{Otter2024,
author = {Otter, Clayton J and Bracci, Nicole and Parenti, Nicholas A and Ye, Chengjin and Asthana, Abhishek and Blomqvist, Ebba K and Tan, Li Hui and Pfannenstiel, Jessica J and Jackson, Nathaniel and Fehr, Anthony R and Silverman, Robert H and Burke, James M and Cohen, Noam A and Martinez-Sobrido, Luis and Weiss, Susan R},
title = {SARS-CoV-2 nsp15 endoribonuclease antagonizes dsRNA-induced antiviral signaling},
journal = {Proceedings of the National Academy of Sciences},
year = {2024},
volume = {121},
number = {15},
doi = {10.1073/pnas.2320194121}
}
EUVIMED